Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study | PLOS ONE
![The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors - Clinical Lung Cancer The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/519ac6a4-ee1d-4cdf-9d7f-3925cb6d4a10/gr1.jpg)
The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors - Clinical Lung Cancer
![Abstract 11978: Impact of Heart Rate and Beta-blockers on Mortality in Patients With Heart Failure and Preserved Ejection Fraction | Circulation Abstract 11978: Impact of Heart Rate and Beta-blockers on Mortality in Patients With Heart Failure and Preserved Ejection Fraction | Circulation](https://www.ahajournals.org/cms/asset/6cf45e91-309b-4fd9-a0ea-37e533a79368/g11978.jpg)
Abstract 11978: Impact of Heart Rate and Beta-blockers on Mortality in Patients With Heart Failure and Preserved Ejection Fraction | Circulation
![Overall survival of (A) Beta blocker vs. no beta blocker (adjusted for... | Download Scientific Diagram Overall survival of (A) Beta blocker vs. no beta blocker (adjusted for... | Download Scientific Diagram](https://www.researchgate.net/publication/361767418/figure/fig2/AS:1174665108172800@1657073394214/Overall-survival-of-A-Beta-blocker-vs-no-beta-blocker-adjusted-for-age-ECOG_Q320.jpg)
Overall survival of (A) Beta blocker vs. no beta blocker (adjusted for... | Download Scientific Diagram
![Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure - International Journal of Cardiology Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/01d98ed1-1213-433d-9a6f-17c73224ff99/gr1_lrg.jpg)
Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure - International Journal of Cardiology
![BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced. - ppt download BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced. - ppt download](https://images.slideplayer.com/25/8248268/slides/slide_7.jpg)
BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced. - ppt download
![Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation | BMC Gastroenterology | Full Text Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation | BMC Gastroenterology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12876-019-1155-1/MediaObjects/12876_2019_1155_Fig1_HTML.png)